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TGFβ signaling is associated with 
changes in inflammatory gene 
expression and perineuronal net 
degradation around inhibitory 
neurons following various 
neurological insults
Soo Young Kim  1, Vladimir V. Senatorov Jr.2, Christapher S. Morrissey1, Kristina Lippmann3,9, 
Oscar Vazquez2, Dan Z. Milikovsky4, Feng Gu5, Isabel Parada5, David A. Prince5, Albert J. 
Becker6, Uwe Heinemann3, Alon Friedman4,7 & Daniela Kaufer1,2,8
Brain damage due to stroke or traumatic brain injury (TBI), both leading causes of serious long-term 
disability, often leads to the development of epilepsy. Patients who develop post-injury epilepsy 
tend to have poor functional outcomes. Emerging evidence highlights a potential role for blood-brain 
barrier (BBB) dysfunction in the development of post-injury epilepsy. However, common mechanisms 
underlying the pathological hyperexcitability are largely unknown. Here, we show that comparative 
transcriptome analyses predict remodeling of extracellular matrix (ECM) as a common response to 
different types of injuries. ECM-related transcriptional changes were induced by the serum protein 
albumin via TGFβ signaling in primary astrocytes. In accordance with transcriptional responses, we 
found persistent degradation of protective ECM structures called perineuronal nets (PNNs) around fast-
spiking inhibitory interneurons, in a rat model of TBI as well as in brains of human epileptic patients. 
Exposure of a naïve brain to albumin was sufficient to induce the transcriptional and translational 
upregulation of molecules related to ECM remodeling and the persistent breakdown of PNNs around 
fast-spiking inhibitory interneurons, which was contingent on TGFβ signaling activation. Our findings 
provide insights on how albumin extravasation that occurs upon BBB dysfunction in various brain 
injuries can predispose neural circuitry to the development of chronic inhibition deficits.
Brain damage due to stroke or brain trauma often yields neuronal hypersynchrony, potentially resulting in epi-
lepsy and ensuing cognitive morbidities1, 2. Since no effective therapy exists for the prevention of injury-induced 
epilepsy, it is critical to identify key steps underlying the delayed pathological hyperexcitability. Insults to the 
brain commonly involve lasting dysfunction of the blood-brain barrier (BBB) formed by tight junctions between 
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endothelial cells and ensures brain homeostasis by limiting the entry of blood-derived factors into brain paren-
chyma3. We have previously shown that chemically-induced disruption of the BBB induces pathological hyper-
excitability manifested by epileptiform activity and recurring seizures4. We have further shown that exposure of 
the typically-secluded brain environment to albumin, the most abundant blood protein, is sufficient to induce 
epileptiform activity and recurring seizures, and this depends on activation of TGFβ signaling4–7. In the brain, 
albumin is uptaken into astrocytes, binds and activates TGFβ receptors, and can elicit aberrant rewiring of neural 
circuits including abnormal synaptic plasticity8 and excessive excitatory synaptogenesis6. However, a great deal is 
still unknown about the mechanisms by which BBB disruption and the consequent TGFβ signaling activation are 
linked with the delayed inhibitory circuit dysfunction following brain damage.
Despite differences in etiologies, clinical sequelae, and affected brain regions, striking similarities exist in 
the chronic deficits of inhibitory signaling, as repeatedly demonstrated in rodent injury models (summarized 
in Supplementary Table S1). Thus, we performed comparative analyses using human hippocampal samples as 
well as five different rat models of neurological insults in search of shared mechanisms. These include partial 
cortical isolation (“undercut”) as a model of traumatic brain injury9, 10, photothrombosis as a model of ischemic 
stroke11, 12, chemically-induced focal BBB disruption4, 5, direct brain exposure to serum albumin4 or TGFβ17, and 
chronic pharmaco-resistant temporal lobe epilepsy in human patients. We show that a common transcriptional 
signature across rodent models predicts TGFβ-regulated extracellular matrix (ECM) remodeling. Accordingly, 
specialized ECM structures called perineuronal nets (PNNs) around fast-spiking inhibitory interneurons were 
degraded in the undercut rodent cortex. Next, infusion of albumin into a naïve mouse brain was used to test if 
albumin exposure is sufficient to induce the PNN degradation. Indeed, albumin lead to PNN degradation, and 
that was attenuated by losartan, previously shown to block TGFβ-signaling13. Finally, hippocampi resected from 
pharmaco-resistant temporal lobe epilepsy patients were analyzed. Similar to the mice and rat brains, there was an 
increase in TGFβ activation in astrocytes, and degradation of PNNs around fast-spiking inhibitory interneurons 
in epilepsy patients compared to age-matched controls. Our findings suggest that albumin-activated TGFβ sign-
aling alters the microenvironment around inhibitory interneurons, as a potential mechanism underlying delayed 
deficits in neural inhibition following different injuries to the brain.
Results
Early blood-brain barrier disruption is evident in the undercut cortex and peri-infarct hip-
pocampus. BBB dysfunction had been previously reported to occur following TBI, stroke, and brain infec-
tions2. To test our hypothesis that BBB dysfunction is a precipitating event for injury-induced hyperexcitability, 
we first confirmed albumin extravasation in brain regions with hyperexcitable network activity in the injury 
models used in this study – peri-infarct hippocampus following photothrombotic cortical stroke11, 12 and par-
tially isolated undercut cortex9. Evans-blue, an albumin-binding dye was intravenously administrated 12 hours 
after photothrombosis or the undercut surgery and detected in the peri-infarct cortex and hippocampus and 
around the partially-isolated cortical region (Fig. 1a). Immunostaining further confirmed albumin extravasation 
in the ipsilesional cortex at 24 hours following the undercut operations as well (Fig. 1b). Consistent with previous 
findings of albumin extravasation in rodent6 and human14 epileptic brains, albumin was co-localized within cells 
expressing glial fibrillary acidic protein (GFAP), a marker for astrocytes, in the undercut cortex (Fig. 1c).
Functional annotation analysis reveals TGFβ-regulated transcriptional activation as an early 
common response to different insults. In search of commonality in the early transcriptional response to 
injuries and/or BBB dysfunction, we compared transcriptome profiles of the peri-infarct hippocampi and under-
cut cortices with three models for BBB dysfunction –BBB disruption induced by sodium deoxycholate (DOC) and 
direct cortical exposure to serum albumin or TGFβ1. Heat maps of genes annotated for inflammation and TGFβ 
signaling (Supplementary Fig. S1) show transcriptional induction. In order to identify a common transcriptional 
response across models, we used a vote counting method as previously described for large-scale meta-analysis15. 
Expression values for over 22,000 rat genes were scored and received a vote for each experiment in which the gene 
was dysregulated at 24 hours following insult (stroke, undercut, DOC, albumin, or TGFβ1). A total of 94 genes 
were found to be consistently upregulated across models (vote counts ≥ 4, Fig. 1d and Supplementary Fig. S2). 
Down regulated genes showed less consistency across models, with only two genes dysregulated in ≥4 conditions, 
and therefore were not further analyzed for functional annotation (Fig. S2). Annotation enrichment analysis on 
the list of upregulated genes identified plasma membrane, extracellular regions, and cell projections as enriched 
cellular components in the 94 genes (Fig. 1e, p’s < 0.05). The overrepresented Kyoto Encyclopedia of Genes and 
Genomes (KEGG) pathways included mitogen-activated protein kinase (MAPK) signaling, chemokine signaling, 
focal adhesion, cytokine-cytokine receptor signaling, indicating cell-matrix-cytokine interactions and massive 
inflammation as the common thread in early response to different injuries accompanying albumin extravasation 
(Fig. 1e).
We next explored which transcriptional factor motifs are enriched in the promoters of the commonly regu-
lated genes. The motifs for AP1, NFκB (p65), and ETS1 were significantly overrepresented in the promoters of 
the commonly regulated genes (Fig. 1g). Both AP1, a Jun/Fos dimer transcription factor, and NFκB are known 
to be associated with Stat3 signaling16 as well as directly regulated by the TGFβ signaling pathway17, 18. ETS1 
is an effector of the TGFβ signaling pathway19. Co-administration of TGFβ receptor blockers attenuated such 
transcriptional activation of majority of the commonly regulated genes upon albumin exposure (Fig. S3). These 
findings demonstrate that albumin-induced changes in gene expression are dependent on activation of TGFβ 
signaling pathways. To demonstrate the regulatory role of TGFβ in brain injury response, future experiments will 
need to directly test the effect of TGFβ blocker on ECM genes after brain injury.
www.nature.com/scientificreports/
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Transcriptional activation of extracellular matrix genes is evident across models. One of the 
prominent events driven by the activation of TGFβ signaling is the modulation of extracellular matrix (ECM), 
which is essentially involved in epithelial to mesenchymal transition (EMT). EMT plays a central role in mor-
phogenesis during early development and pathological processes such as tissue fibrosis and tumor invasion that 
require cell migration and ECM remodeling18. Likewise, AP117, NF-κB20, ETS119 and MAPK17 signaling pathways 
are key players in EMT-related ECM modulation. Given that ECM composition substantially affects synaptic 
function21, we hypothesized that ECM remodeling driven by TGF-β signaling following injuries might be asso-
ciated with pathological hyperexcitability of neural networks occurring at a later time point. Therefore, we first 
explored the possibility that similar changes of ECM occur in the brain as a common response to epileptogenic 
injuries and BBB dysfunction. We examined the expression levels of selected genes that either encode ECM struc-
tural components or are involved in ECM remodeling across the five models (Fig. 2). The ECM components 
tenascin C (Tnc) and neurocan (Ncan) were highly increased 24 hours after all insults (Fig. 2a,b). In contrast, 
the expression of hyaluronan and proteoglycan link protein (Hapln) 1 that governs the structural integrity of 
ECM, was decreased at both 7/8 and 24 hours following chemically-induced BBB disruption and exposure to 
albumin or TGFβ1 (Fig. 2a). The expression of genes encoding for proteins involved in ECM degradation such 
as matrix metalloproteinase (MMP) 9, MMP14, and a disintegrin and metalloproteinase with thrombospondin 
type 1 (Adamts1), were consistently upregulated across models (Fig. 2c). Together, these transcriptional changes 
predict a considerable remodeling of the ECM.
ECM surrounding fast-spiking inhibitory interneurons is degraded in the injured cortex. This 
predicted ECM alteration is interesting as it may be associated or even causatively involved in chronic deficits of 
inhibitory signaling and pathological hyperexcitability observed following injury. Particularly, a specialized ECM 
structure named perineuronal nets (PNNs)22 is tightly associated with parvalbumin (PV) expressing fast-spiking 
inhibitory interneurons. These interneurons play a critical role in the regulation of hyperexcitable network activ-
ity, and are responsible for the generation of gamma oscillations, enabling coordinated activation of ensembles 
of principal cells23. Functional deficits of fast-spiking interneurons are a key pathological factor in epilepsy24 and 
are also found in the injured brain. Indeed, it has been previously reported that reduced perisomatic inhibition 
and structural abnormality of fast-spiking interneurons are seen in the undercut cortex9, 10. Gamma oscillations 
Figure 1. Comparative analysis revealed a common transcriptional signature in hyperexcitable regions 
following different insults. (a) Evans blue extravasation indicating BBB disruption in the peri-infarct 
hippocampus (outlined with white dotted line) and around the partially-isolated cortical regions 12 hours 
after stroke (left) and the undercut operation (right). (b) Representative micrograph of a rat brain slice 
immunostained for albumin (Alb) at 24 hours following the undercut (UC) operation (indicated by white dotted 
line). Scale bar = 1mm. (c) Representative confocal images of the UC cortex showing co-localization (white 
arrowheads) of albumin with GFAP (+) astrocytes. Nuclear staining with DAPI (blue) in the merged image. 
Scale bar = 20 μm. (d) A vote counting method for five independent microarray datasets from the undercut 
cortex (UC), peri-infarct hippocampus (Stroke), BBB-disrupted cortex treated with sodium deoxycholate 
(DOC), and cortices exposed to albumin (Alb) or TGFβ1 (TGFβ). (e) The gene ontology (GO) term enrichment 
analysis in the common transcriptional profile. (f) Using HOMER software, motifs including AP-1, NFκB, and 
ETS1 were found significantly enriched in the promoter proximal region, ±500 base pairs of the commonly 
upregulated genes across models.
www.nature.com/scientificreports/
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are reduced in the peri-infarct hippocampus following ischemic cortical stroke as well12. We first examined 
whether PNN degradation occurs in the injured brain. Co-staining of wisteria floribunda agglutinin (WFA), a 
broad marker labeling PNNs, with immunostaining for parvalbumin (PV), a marker for fast-spiking interneurons 
revealed significant main effects of time and undercut treatment on the percentage of PV(+)/WFA(+) interneu-
rons (Fig. 3a,b and Supplementary Fig. S3). The percentage of PV(+)/WFA(+) cells out of a total number of 
PV(+) interneurons was significantly decreased in the undercut cortex at 7 days following injury, compared to 
the contralateral homotopic region (Fig. 3c). It should be noted that a total number of WFA(+) cells were decreased 
at 7 days following injuries (Contralateral vs. Ipsilateral, 451.44 ± 47.78 vs. 243.78 ± 37.23 cells per mm2, p < 0.05, 
two-tailed student t-test), while the percentage of non-PV cells labeled with WFA in the somatosensory cortex 
was not significantly altered by the undercut injuries (%PV(−)WFA(+) out of WFA (+) cells, Contralateral vs. 
Figure 2. Transcriptional activation of TGFβ-regulated extracellular matrix genes across models. The 
expression levels of genes encoding for extracellular matrix (ECM) components (a) and for molecules involved 
in ECM remodeling (c) are shown across models. Heat maps are based on a log2 scale. (b) Quantitative real-
time PCR was used to measure mRNA level of Tnc in the undercut (UC) cortex and peri-infarct hippocampi 
(Stroke). One way ANOVA with posthoc Turkey’s test (in Stroke, B) and student t-test (in UC). The number of 
animals used per condition is indicated within the bar.
www.nature.com/scientificreports/
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Ipsilateral, 58.4 ± 6.98 49.5 ± 9.94, p = 0.491, two-tailed). This implies that not only PNNs around PV cells are 
degraded, but the ECM structures labeled with WFA around non-PV cells might be also affected by injury.
Albumin increases the expression of ECM genes in astrocytes via TGFβ/Alk5 pathway. 
Previously we have shown that albumin activates astrocytic TGFβ signaling via TGFβ receptor type I activin 
receptor-like kinase 5 (Alk5), leading to the increased phosphorylation of Smad2/3, the proximate effector of 
TGFβ signaling pathways in astrocytes, but not in neurons4. We therefore next examined whether the effect of 
albumin on those genes are mediated by TGFβ-receptor signaling, using cortical tissue collected 24 hrs following 
exposure to albumin or albumin plus TGFβ receptor blockers (as in ref. 7). The expression level of eight ECM 
genes robustly upregulated across the five models (shown in Fig. 2) was attenuated in the presence of TGFβ 
receptor blockers (Fig. 4d and Fig. S4), suggesting that albumin-induced activation of ECM genes requires the 
activation of TGFβ receptor-mediated signaling.
Next, we asked what is the cellular source of the ECM-related transcriptional response. We treated primary rat 
cortical cultures enriched for astrocytes or neurons with albumin for 24 hours. Following albumin exposure, the 
mRNA levels of Serpina3n, Serpine1, Timp1, Ncan, and Tnc, were significantly increased in astrocytes (Fig. 4b–f), 
consistent with the results in the in vivo models. In contrast, albumin exposure did not modulate their mRNA 
levels in neuronal cultures (Fig. 4b–e). Additionally, the mRNA expression of connective tissue growth factor 
(CTGF), a key regulator for TGFβ-mediated EMT by governing the transcription of ECM molecules18, was also 
increased in astrocytes but not in neurons upon albumin exposure (Fig. 4g). Albumin-induced transcriptional 
modulation in cultured astrocytes was blocked in the presence of the selective ALK5 blocker, SJN2511(Fig. 4b–g).
Albumin exposure is sufficient to induce persistent degradation of ECM around fast-spiking 
inhibitory interneurons. We next addressed the question whether albumin extravasation was responsible 
for the PNN degradation observed in the injured brain. To test that, we exposed mice to albumin intracere-
broventricular (icv) infusion. Animals were implanted with icv osmotic pumps delivering albumin or artificial 
cerebrospinal fluid (aCSF) for 7 days and sacrificed at different time points post implantation (Fig. 5a). This 
model was chosen as we have previously shown that it enables the chronic controlled infusion of albumin to the 
hippocampus and induces spontaneous seizures6. First, we investigated whether the chronic exposure to albumin 
induces changes in proteins involved in ECM remodeling, as predicted by the transcriptional analysis using the in 
vivo models (Fig. 2). Western blot analysis revealed significantly increased levels of MMP9, TIMP1, and STAT3 
proteins in the hippocampus of animals that received albumin infusion compared with those exposed to aCSF 
(Fig. 5b–c). Accordingly, Mmp9, Timp1, and Stat3 mRNA levels were also upregulated across the different in 
vivo models (Fig. 2 and Supplementary Fig. S2). MMP14 protein level was not statistically significant different in 
albumin-infused vs. control animals.
Next, we tested whether albumin exposure by itself is sufficient to induce degradation of PNNs around 
fast-spiking interneurons. We estimated the percentage of PV(+) cells that are enwrapped by WFA(+) ECM 
structures in the hippocampus of mice at different time points following pump implantation. Consistent with 
findings in the rat undercut cortex, the percentage of PV(+)/WFA(+) interneurons in the mouse hippocampus 
was significantly decreased following 7 days of albumin exposure, compared to control mice infused with aCSF 
(Fig. 5b and Supplementary Fig. S5). Decreases in the percentage of PV(+)/WFA(+) cells in albumin-infused 
hippocampi were persistently found 23 days after the removal of osmotic pumps (Fig. 5b,c). These findings sug-
gest that exposure of a naïve brain to albumin is sufficient to result in chronic PNN degradation, as found in the 
injured cortex.
Figure 3. Perineuronal nets around PV(+) interneurons are degraded following traumatic brain injury. (a) 
Time line of experimental design. (b) Representative confocal images of rat undercut and contralateral (Cont) 
cortices stained for parvalbumin (PV) and perineuronal nets using Wisteria Floribunda agglutinin (WFA) 
7 days after the operation. Scale bar = 50 µm. White arrowheads indicate representative PV(+)/WFA(+) 
cells. Areas within white rectangles in merged images are shown magnified. (c) The percentage of PV(+) 
interneurons associated with PNNs was significantly decreased at 7 days following the undercut operation. 
*p < 0.05, Two-way ANOVA with post-hoc Sidak’s test, two tailed. Three biological replicates (n’s = 3) were used 
at each time point.
www.nature.com/scientificreports/
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Losartan blocks albumin-induced chronic degradation of ECM around PV(+) interneurons. 
Losartan, an FDA approved angiotensin II type 1 receptor antagonist, has been shown to inhibit TGFβ 
signaling-driven ECM remodeling13, 25. We have previously shown that losartan blocks albumin-induced TGFβ 
signaling and prevents the development of recurring seizures4. We implanted mice with osmotic pumps that 
delivered icv infusion of losartan with albumin or aCSF for 7 days and examined the association between PNNs 
and PV(+) interneurons in the hippocampus at 30 days post implantation. In the presence of losartan, the per-
centage of PV(+)/WFA (+) interneurons in animals treated with albumin was not different from controls infused 
with aCSF (Fig. 5b and d), indicating that losartan administration blocked albumin-induced PNN degradation 
around PV+ cells.
Activated astrocytic TGFβ signaling and PNN degradation are found in hippocampal sections 
from patients with chronic epilepsy. Because BBB dysfunction and albumin uptake into astrocytes 
were previously demonstrated in the hippocampi of temporal lobe epilepsy (TLE) patients14, we predicted 
that albumin-induced TGFβ signaling activation and subsequent PNN degradation may also occur in the hip-
pocampus of TLE patients. Phosphorylation of Smad2 (pSmad2) proteins was quantified as a marker of TGFβ 
receptor-mediated signaling in hippocampal tissues resected from TLE patients (detailed information is available 
in Supplementary Table S2) and autopsy controls. The number of GFAP (+) astrocytes co-localized with pSmad2 
protein was significantly increased in hippocampal sections of TLE patients compared to controls (Fig. 6a and b). 
Consistent with our findings in the rodent brains the percentage of PV(+)/WFA(+) interneurons was 
Figure 4. Albumin activated the transcriptional responses of ECM genes via TGFβ receptor signaling. (a) The 
expression levels of ECM-related genes is upregulated across models (marked in bold in A, C) in a separate 
microarray data set in comparisons between albumin vs. albumin + TGFβ receptor (R) blockers. **p = 0.0078, 
Wilcoxon signed-rank test, two-tailed. (b–g) Quantitative real-time PCR for the mRNA expression of selected 
genes in primary cortical astrocytic or neuronal cultures at 24 hours following treatment of albumin or albumin 
plus a specific Alk5 blocker, SJN2511. Results were of three independent primary culture derivations (n = 11 
per condition in neurons; n = 10–12 per condition in astrocytes). One way ANOVA with posthoc Turkey’s test 
(in astrocytes) and student t-test (in neurons) were performed. Cont, control; Alb, albumin; SJN, SJN2511; 
n.d., non detectable (Cq value ≥ 35). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Data are shown as 
mean ± S.E.
www.nature.com/scientificreports/
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significantly decreased in the hippocampus resected from TLE patients in compared with controls (Fig. 6c and d). 
These results corroborate the potential role of TGFβ-regulated ECM remodeling in the pathology of chronic 
hyperexcitability.
Discussion
The present study was designed to address the question whether different types of injuries (with different eti-
ologies) involve acute transcriptional responses, and if so, do any common changes emerge that can explain 
inhibitory deficits known to commonly be found following neurological insults including stroke, traumatic brain 
injury, and BBB breakdown? We compared transcriptional responses at an early time point (within 24 h) follow-
ing different types of insults. We identified a common transcriptional response including genes encoding for key 
molecules involved in ECM remodeling and found the induction of proteins of a subset of those genes as a result 
of albumin exposure in vivo. Indeed, PNN degradation was apparent at least 7 days after insults and persistent 
until 30 days post initial insult.
Given its association with a wide range of cellular processes, TGFβ signaling pathway has long been a thera-
peutic target in many diseases including various types of cancer. Here, we show that the common transcriptional 
activation predicts TGFβ-regulated ECM remodeling as a common response to different insults, and the degra-
dation of perineuronal nets (PNNs), an ECM structure tightly associated with fast-spiking inhibitory interneu-
rons is found in the injured brain at a later time point. Albumin extravasation into the brain parenchyma, which 
often occurs when BBB function is compromised, emerges as a potential regulator, as exposure to albumin alone 
Figure 5. Albumin induced the degradation of perineuronal nets around PV(+) interneurons and losartan 
attenuated the effect of albumin. (a) Experimental design. Intracerebroventricular (ICV) osmotic pumps 
containing albumin (0.4 mM) or aCSF were implanted in rats and mice and removed after 7 days. (b,c) 
Molecules involved in ECM remodeling including MMP9, TIMP1, and STAT3 were significantly increased in 
dissected rat hippocampi following albumin infusion for 7 days. Uncropped blot images are available in the 
Supplementary Fig. S4. Each group has four biological replicates. Unpaired student t- test. *p < 0.05, two-tailed. 
(d) Representative confocal images showing PNNs (WFA) and PV(+) cells in the mouse hippocampal CA1 
region at 30 days post implantation. (e) A separate set of animals was infused with albumin + losartan (10μM) 
or aCSF + losartan. Scale bar = 50 μm. (f) Albumin exposure decreased the association of PNNs with PV(+) 
interneurons (*p < 0.05, **p < 0.01, ***p < 0.001, Two-way ANOVA, post-hoc Sidak’s test, two tailed). Co-
administration of losartan attenuated the effect of albumin (p > 0.05, Mann-Whitney test, two-tailed). n.s., not 
significant. Each condition has three or four biological replicates (n = 3–4).
www.nature.com/scientificreports/
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was sufficient to induce similar transcriptional changes and degradation of PNNs around PV+ interneurons. 
Considering the critical role of ECM in synaptic plasticity and function21, 26 as well as the known effect of albumin 
on excitatory synaptogenesis6, we propose a working model for the development of chronic hyperexcitability 
following brain damage (Fig. 6e). BBB dysfunction, evident after various types of injuries, allows the entry of 
albumin into the brain. Albumin induces an early transcriptional response via activation of TGFβ receptors, 
specifically related to inflammation and ECM remodeling. This in turn potentially generates a microenvironment 
promoting neuroanatomical reorganization, including aberrant excitatory synaptogenesis and PNN degrada-
tion around inhibitory interneurons, that all together can potentially lead to the development of pathological 
hyperexcitability.
The signaling pathways that emerge as activated across models in the present study- MAPK, NFκB, AP-1, and 
ETS1 - are well known to play a significant role in inflammation16, 27–29. Recently, inflammation has gained much 
interest as a possible therapeutic target for the prevention of epilepsy development due to its role in the patho-
logical progression30, 31. Inflammation accompanies massive migration of cells and cytokines, which not only 
requires, but also elicits ECM remodeling32. The tight association between ECM remodeling and inflammation 
had been reported in the central nervous system (CNS). For example, in the inflamed spinal cord, ECM compo-
nents such as neurocan and tenascin C are abnormally upregulated, while hyaluronan and aggrecan, the main 
components maintaining scaffolding and matrix structure, are progressively degraded, concomitant with the 
persistent upregulation of matrix metalloproteinases (MMPs)33. Interestingly, neurocan and tenascin C are not 
only abundantly expressed by reactive astrocytes following brain injury34, but also greatly upregulated following 
Figure 6. Increased expression of astrocytic pSmad2 and reduced association of PNNs around PV(+) cells 
in human epileptic hippocampi. (a) Representative micrographs of human hippocampi stained for GFAP 
and phosphorylated Smad2, a downstream effecter of TGFβ signaling. The hippocampi were resected from 
temporal lobe epilepsy (TLE) patients or age-matched autopsy controls. Representative GFAP(+) astrocytes 
expressing pSmad2(+) are indicated by white arrowheads. Scale bar = 50 μm. (b) Co-localization of pSmad2 
with GFAP was increased in TLE patients (n = 5) compared to controls (n = 3). (c) Representative confocal 
micrographs of human hippocampal tissues stained for GFAP, PV, and PNNs (WFA) resected from TLE patients 
or controls. Scale bar = 50 μm. White and blue arrowheads indicate representative PV(+)/WFA(+) and PV(+)/
WFA(−) cells, respectively. (d) The percentage of PV(+)/WFA(+) cells was decreased in the hippocampus 
of TLE patients (n = 4) compared to controls (n = 4). Mann-Whitney test, two-tailed, was used for statistical 
analyses. *p < 0.05. (e) A working model. Several points for feed-forward loops (i-iii) can lead to chronic 
hyperexcitability and the development of epilepsy. The dysfunction of blood-brain barrier (BBB) and the 
ensuing entry of albumin into brain parenchyma activate TGFβ signaling. Comparative transcriptome analyses 
predicted the activation of the common core signaling transduction including MAPK pathway, Stat3, NFκB, 
AP-1, and ETS1. These signaling pathways can elicit the reciprocal activation of inflammation and extracellular 
matrix (ECM) remodeling (i). ECM remodeling can trigger the transformation of a latent from of TGFβ to its 
active form75 as well as exacerbate BBB dysfunction58 (ii). The degradation of perineuronal nets (PNNs) around 
fast-spiking interneurons and aberrant excitatory synaptogenesis occur in the course of ECM remodeling, 
presumably leading to functional alterations in inhibition and abnormality in synaptic plasticity that may 
contribute to excitation/inhibition (E/I) imbalance and ultimately the occurrence of seizures. Finally, seizures 
per se cause BBB dysfunction, inflammation, and the upregulation of MMPs activity31, 43 (iii).
www.nature.com/scientificreports/
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status epilepticus35, 36. Therefore, our finding that albumin increases mRNA levels of tenascin C and neurocan in 
astrocytes via TGFβ/Alk5 pathway supports a critical role of astrocytic TGFβ signaling in inflammation-coupled 
changes of ECM during epileptogenesis.
Emerging evidence highlights the importance of ECM for synaptic plasticity21, 37. While in the present study 
we quantified PNNs around fast-spiking inhibitory interneurons, it should not be ruled out that albumin extrava-
sation and subsequent transcriptional responses in ECM-related genes may affect ECM structures around differ-
ent types of cells and alter synaptic plasticity of other types of neurons besides PV(+) interneurons. For instance, 
the upregulation of MMP9 has been found to induce excessive excitatory synaptogenesis in rodent epilepsy mod-
els38. Given our previous finding that albumin increases excitatory synaptogenesis via TGFβ signaling6, such 
ECM remodeling may contribute to excitatory synaptogenesis. It has been previously reported that hippocampal 
neurons derived from transgenic mice that lack four ECM molecules – the glycoproteins, Tenascin C and R, and 
the chondroitin sulfate proteoglycans (CSPGs), brevican and neurocan – shows abnormalities in synaptic struc-
ture and function21. Upregulation of astrocyte-derived tenascin C is associated with neurite outgrowth following 
injury39. Therefore, it seems reasonable to speculate that ECM remodeling would affect not only PV(+) cells 
but also various types of neurons and their synaptic plasticity. Notably, it has been reported that although PNNs 
labeled by WFA are found primarily around PV(+) interneurons, they are also found surrounding other types of 
cells including glutamatergic neurons40. Indeed, we have found WFA(+)/PV(−) cells both in the injured cortex 
(Fig. 3) and hippocampus chronically exposed to albumin (Fig. 5). Given the heterogeneity in PNNs and the cell 
types surrounded by them41, alterations in ECM could result in a broad spectrum of changes in synaptic func-
tion and neural connectivity. Further studies are necessary to dissect how ECM remodeling driven by albumin 
extravasation differentially affects various types of cells.
Previous studies reported the association between PNNs and hyperexcitable networks. The administration of 
kainic acid, an epileptogenic agent, was recently shown to induce changes in components of PNNs, which ham-
pers the maturation of PV(+) cells in the rodent cortex and hippocampus42. PNNs around PV(+) interneurons 
in the rat hippocampus were found to be degraded following status epilepticus induced by pilocarpine, concom-
itant with the increased activity of MMPs43, and inhibition of MMPs can prevent seizure development as well 
as PNN degradation in kindled rats44. A recent study by Hsieh and colleagues reported that PNN degradation 
preceded PV(+) cell impairment and loss of cortical inhibition following traumatic brain injury45, corroborating 
our hypothesis that PNN degradation predisposes injured brains to inhibitory dysfunction. Given our finding 
that albumin exposure per se can drive the chronic degradation of PNNs, we suggest that BBB dysfunction occur-
ring in the injured brain contributes to injury-induced PNN degradation and eventually deficits of inhibition.
The pathological consequences of degraded PNNs and the electrophysiological traits of PV(+) interneurons 
following the loss of PNNs are still largely unknown. Technical limitations hinder manipulating PNNs exclusively 
due to the overlap in the components of PNNs and other ECM structures46. However, the functional roles of 
PNNs during the early postnatal development have been extensively studied. For example, PV(+) interneurons 
play a critical role in the maturation of developing local circuits in the visual cortex47. PNNs specifically capture 
and transfer othodenticle homeobox 2 (Otx2), an essential protein for the maturation of PV(+) interneurons48 
into the cells49. It has been reported that Otx2 has a neuroprotective effect by restoring mitochondrial dysfunction 
in mice retinas50. Furthermore, PNNs are found to protect PV(+) interneurons against oxidative stress in rodent 
prefrontal cortex51. In fact, PV(+) interneurons are particularly vulnerable to oxidative stress due to their intrin-
sic electrophysiological properties that feature high energy demand and require a high level of mitochondrial 
oxidative capacity52. A recent study showed that the increased level of oxidative stress was concomitantly found 
with a gradual loss of cortical inhibition following brain injury45. Notably, brain injuries as well as seizures induce 
heightened oxidative stress along with chronic inflammation2, 30, 31. Therefore, it is plausible to speculate that the 
chronic loss of PNNs due to BBB disruption renders the PV(+) interneurons more susceptible to mitochondrial 
dysfunction against oxidative stress, leading to functional deficits of those cells and reduced inhibition in local 
circuits. Further study is required to elucidate the pathological role of degraded PNNs around PV(+) interneu-
rons and to examine whether the heightened level of oxidative stress is a key factor linking PNN degradation with 
chronic deficits of inhibitory signaling following injuries.
In addition to its preventive effect on epileptogenesis via TGFβ suppression4, losartan blocked the effect of 
albumin on the association of PNNs with PV(+) interneurons. As mentioned above, given that seizures can 
induce increased inflammation and MMP activity43, we cannot rule out the possibility that the effect of losar-
tan on PNNs may in part result from its suppression of seizures. However, it has been repeatedly demonstrated 
that losartan normalizes pathological changes of ECM via TGFβ suppression13, 25, 53, supporting that its potent 
inhibitory effects on TGFβ-induced ECM remodeling may directly attenuate the albumin-induced degradation 
of PNNs.
Notably, there are conflicting reports in regards to TGFβ signaling, as being neuroprotective or neurotoxic. 
Prehn and colleagues (1993) reported that the administration of TGFβ1 prior to the onset of ischemic stroke 
reduces neuronal damage54. Transgenic mice whose astrocytic TGFβ signaling is inhibited were shown to have 
increased inflammation and reduced functional outcome following stroke compared to wild-type mice55. On 
the other hand, transgenic mice over-expressing TGFβ1 in astrocytes developed seizures and overexpression of 
ECM molecules56. Blocking TGFβ-Smad2/3 signaling in innate immune cells reduced deposits of cerebrovascu-
lar beta amyloid in the Alzheimer’s disease model57. While the increased circulating TGFβ1 has been found to 
exacerbate BBB permeability in a mouse model of hepatic encephalopathy via upregulation of MMP958, it has 
been also reported that macrophages play a critical role in maintaining integrity of BBB following stroke via 
TGFβ159. These conflicting findings seem to highlight the context-dependent role of post-injury TGFβ signaling. 
Given that the current findings on the linkage between TGFβ signaling and PNN degradation around inhibitory 
interneurons point strongly to a possible use of TGFβ blockers as a preventive therapy for acquired epilepsy, 
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further investigation is required to elucidate the mechanisms underlying the beneficial and detrimental effects of 
TGFβ signaling in the pathological sequelae following brain damage.
In line with the context-dependent role in injury-induced pathology, some preclinical studies have reported 
the neuroprotective effect of albumin in rodent stroke models, suggesting albumin exposure as a potential clinical 
therapy60, 61. Indeed, there was a large-scale clinical trial to test its beneficial effects in stroke patients. According 
to a recent report62, however, albumin administration has no therapeutic benefits and is in fact associated with 
greater adverse events such as increased rates of intracerebral hemorrhage or pulmonary edema. Although such 
discrepancy between preclinical evidence and the clinical trial remains unexplained yet62, the effect of albumin 
exposure shown in the present study might contribute in part to its adverse effect. We used albumin at a concen-
tration up to the one corresponding to 100% of serum concentration (0.4 mM) with an assumption of maximum 
disruption of BBB. Given that stroke involves BBB dysfunction and its extent may vary with infarct sizes, addi-
tional albumin administration for stroke patients may induce massive albumin exposure to broad brain regions, 
resulting in adverse events including intracerebral hemorrhage. Furthermore, a temporal window of albumin 
exposure may be a critical factor. In the preclinical study of albumin administration in rodent stroke models, the 
beneficial effect of albumin administration on post-stroke brain swelling was significant only when albumin was 
administered within 4 hours after the onset of ischemic stroke60. In contrast, post-stroke albumin extravasation 
manifested by Evans Blue injections seemed to be maximal at 12 hour after the onset of photothrombosis and 
gradually normalized11. Moreover, subsequent transcriptional responses to the injury was greater at 24 h com-
pared to 12 h following the onset of stroke in the present study, suggesting that the effect of albumin on ECM 
remodeling might be delayed. Further studies are required to elucidate the pathological role of albumin with a 
high temporal resolution following injuries and its long-term consequences.
Upon dysfunction of the BBB, multiple blood-borne elements other than albumin gain access to the 
normally-secluded brain environment, and can potentially initiate a sequence of pathological events. For exam-
ple, fibrinogen from the blood can trigger reactive astrocytosis and increase the expression of neurocan and other 
scar-forming molecules via the activation of TGFβ signaling63. Furthermore, iron has long been regarded as a 
potential trigger for chronic neurodegeneration, particularly found in multiple sclerosis64. It has been reported 
that chronic hemorrhage arising from cerebral cavernous malformation often present with epilepsy in patients65. 
These findings corroborate that the entrance of blood-borne molecules is associated with neuroinflammation and 
pathological hyperexcitability. Furthermore, as we proposed in our working hypothesis (Fig. 6e), a sequence of 
processes from TGF-β regulated transcriptional responses can elicit several feedforward loops to manifest delayed 
worsening of BBB integrity that possibly leads to chronic exposure of the brain parenchyma to blood-borne 
molecules. Since it has been demonstrated that exposure of the brain environment to albumin in the absence 
of injury or BBB dysfunction is sufficient to recapitulate inflammation, neurodegeneration, and epileptogenesis 
(summarized in Supplementary Table S1), we focused on the downstream signaling of albumin extravasation in 
the present study.
BBB dysfunction is tightly associated with other neurodegenerative disorders including Alzheimer’s disease 
and multiple sclerosis66, both of which involve chronic deficits of PV(+) interneurons67, 68. In particular, such defi-
cits of inhibitory interneurons were found to be a critical factor for abnormal network activity and cognitive dys-
function in a rodent model of Alzheimer’s disease68. Furthermore, a gradual disruption of BBB has been recently 
demonstrated in the aging human hippocampi and this was tightly associated with mild cognitive impairment69, 
highlighting a potent role of the chronic BBB disruption in aging-related cognitive dysfunction. Therefore, our 
findings on ECM remodeling upon albumin extravasation may provide a clue on pathogenic mechanisms for a 
broad spectrum of neurological disorders that involve BBB dysfunction.
Methods
Animals. All experimental procedures were approved by the animal care and use ethical committees at the 
University of California Berkeley, Stanford University, Charité University Medicine Berlin, and Ben-Gurion 
University of the Negev, Beer Sheva and were performed in accordance with the appropriate guidelines and regu-
lations. Partial isolation of sensorimotor cortex (“Undercut”) was made in 15 male Sprague-Dawley rats (1 month 
old). Animals were deeply anesthetized with ketamine and xylazine and the scalp of was incised. Cranial window 
over somatosensory motor cortex was made and a 30-gauge needle, bent 90° 2mm from the tip, was inserted 
parasagittally, advanced under direct vision tangentially, and lowered 2mm. The needle was then rotated 180° 
and elevated to beneath the pial vessels, and removed. A second transcortical cut was made parallel and 2mm 
laterally to the first. Animals with sham operations underwent craniectomy only without inserting a needle. For 
RNA extractions, the brain region underneath the cranial window was dissected 24 hour after the operation and 
fresh frozen (Sham, n = 3; Undercut, n = 3). For immunohistochemistry, animals were transcardially perfused 
at 24 hour, 3 days, and 7 days post operation (n’s = 3). For stroke surgeries, 15 male Wistar rats (240–350 g) were 
used and photothrombotic stroke onto somatosensory cortex was made. Animals were anesthetized with keta-
mine and xylazine (i.p., 1.6 and 0.6 mg/kg, respectively). The skin was opened and a halogen light beam (diameter 
3.5 mm) was directed for 15 min onto the intact skull (1 mm posterior and lateral to bregma) after intravenous 
injection of Rose bengal (20 mg/kg). Sham operation (n = 5) consisted of either exposure to a light beam (n = 3) 
or injection of Rose Bengal (n = 2). Peri-infarct hippocampi from animals with stroke were dissected and fresh 
frozen at 12 hour (n = 4) and 24 hour (n = 5) post operations. Sham-operated animals were sacrificed 12 hour 
(n = 2, one with light beam and the other with Rose Bengal) and 24 hour (n = 3, one with light beam and two with 
Rose Bengal) after sham operations. To examine whether blood-brain barrier disruption occurs in hippocampus 
following photothrombotic stroke in rats, we intravenously administered Evans blue, which binds to intrinsic 
albumin, to animals immediately after the induction of photothrombosis and checked for extravasation after 
12 hours, as previously described11.
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Intracerebroventicular osmotic pump implantation. Surgeries were performed on 29 male C57BL/6 J 
mice (3 months old, used for immunihistochemistry) or 14 wistar male rats (10 weeks old, used for Western blot 
analysis) under isofluorane anesthesia (1–2%). Using a sterotaxic frame, a 0.7 mm diameter hole was drilled 
through the skull over the somatosensory cortex (0.5 mm caudal, 1 mm lateral to bregma) and anterior to the hip-
pocampus. The pumps (ALZET, Cupertino, CA) were filled with 200 μL of either bovine serum albumin (0.2 mM 
for rats as previously described4, 0.4 mM for mice, Sigma-Aldrich, St. Louis, MO) solution or 0.4 mM bovine 
serum albumin mixed with 10 µM losartan in artificial cerebrospinal fluid (aCSF) as previously described5, and 
placed subcutaneously between the shoulder blades. We used a concentration of albumin up to 0.4 mM in the icv 
administration corresponding to 100% of serum albumin concentration5, 70. Controls were implanted with pumps 
containing aCSF. Pumps delivered their contents into the right lateral cerebral ventricle via a brain infusion kit 
(ALZET).
RNA extraction and microarray analysis. Total RNA was isolated using TRIzol reagent (Invitrogen, 
Grand Island, NY). The quality of RNA was checked by using the Agilent 2100 Bioanalyzer (Agilent Technologies, 
Santa Clara, CA). Samples were prepared and hybridized to Rat 2.0 ST Arrays (Affymetrix, Santa Clara, CA) 
according to manufacturer’s protocols. Data were normalized and processed as described previously7. Briefly, 
data were preprocessed using the log2 transformation and quantile normalization with the RMA algo-
rithm. Differentially expressed genese were defined as showing a greater than 2 fold change compared to the 
sham-operated groups in each condition, while a minimum expression value of 5 in at least one of the condi-
tions being compared. Gene expression data are available on the Gene Expression Omnibus (GEO, http://www.
ncbi.nlm.nih.gov/geo; accession number GSE81302). The microarray data sets from the previous study7 were 
downloaded from GEO (accession number GSE12304). The previous study used three different types of BBB dys-
function models: the use of BBB disrupting agent, deoxycholic acid (DOC, 2 mM), direct application of albumin 
(0.1 mM, corresponding to 25% of serum albumin cocentration) or TGFβ1 (at a concentration of 10 ng /mL). 
Those concentrations were determined based on the effectiveness to induce hyperexcitability7. The web-based 
program, Database for Annotation, Visualization, and Integrated Discovery (DAVID, http://david.abcc.ncifcrf.
gov/) was used for functional annotation analysis71. Genes showing consistent changes across all experimen-
tal conditions were identified using a vote counting method as previously described in meta-analysis15. While 
down-regulated genes were less consistent across models with only two genes (Abcg2 and Egr1, shown in Fig. S2) 
downregulated in 4 or more conditions, upregulated genes were more consistent yielding a list of 94 dysregulated 
in 4 or more conditions (Fig. S2). Functional annotation analyses were performed on this set of 94 genes includ-
ing gene ontology (GO) enrichment and motif discovery. Expression levels of a subset of those genes were verified 
using quantitative RT-PCR (Fig. S1). Redundant GO terms of cellular components are combined (e.g., extracel-
lular region and extracellular region part). The promoter proximal motif search was performed using HOMER v 
4.7, a software program for ChIP-Seq analysis (http://homer.salk.edu/homer/)72. The promoter proximal region 
was defined as ±500 base pairs of the promoter of interest. Heat maps were made using MATLAB.
Primary rat cortical astrocyte and neuron cultures. For primary rat neuronal cultures, cerebral cor-
tices were collected from embryonic day 18 rats and cells were dissociated using papain solution (10 U/mL, 
Sigma-Aldrich). Mechanical trituration was performed to attain single cell suspension that was then plated. Four 
hours after incubation, the culture medium was replaced with Neurobasal medium (Life Technologies) supple-
mented with 2% B27 and 0.5 mM GlutaMax (Life Technologies). For primary rat astrocytic cultures, cells from 
cerebral cortices of 2-day-old rat pups were prepared as previously reported. Cells were dissociated, plated in 
flasks, and cultured in high-glucose DMEM supplemented with 10% fetal bovine serum and 1% penicillin/strep-
tomycin. After 10 days, flasks were shaken to remove microglia and cells were passaged onto plates. Astrocyte 
cultures were serum-deprived for 18 hour prior to albumin treatment by replacing the medium with serum-free 
high-glucose DMEM supplemented with 1% penicillin/streptomycin. Bovine serum albumin (BSA with a mini-
mum of 98%, fraction V; Sigma-Aldrich) in serum-free media was then given for 24 hours with the final concen-
tration of 0.2 mM. SJN2511 (30 µM, final concentration; obtained from Tocris Biosciences, Minneapolis, MN), a 
TGFβ receptor I blocker, was added 1 hour prior to BSA treatment. All cells were maintained in 5% CO2 at 37 °C.
Real time quantitative PCR. The expression level of mRNA was detected by real time quantitative reverse 
transcriptase-PCR using CFX96 Real Time System (BioRad) with SsoAdvanced SYBR Green Supermix (BioRad). 
Primer sequences are available in Supplementary Information.
Western blot analysis. Tissue was homogenized and protein lysates were extracted from rat hippocam-
pal samples using RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.5% Sodium deoxycholate, 0.1% 
SDS) including a protease (Calbiochem #539134) and phosphatase inhibitor cocktail (Roche PhoStop Ref: 
4906845001). Protein samples were run under reducing conditions–20 μg of protein lysate was mixed with 
Laemmli buffer (Bio-Rad #161–0737), containing 5% 2-mercaptoethanol (Sigma M6250), and fractionated by 
SDS-PAGE using the Mini-PROTEAN® Tetra System and pre-cast TGX™ Gels (Bio-Rad #456-1096); Spectra™ 
Multicolor Broad Range Protein Ladder Thermo #26634) was used as a reference. Following separation, samples 
were transferred to a nitrocellulose membrane (0.45 µm, Bio-Rad #1620115). Membranes were blocked for 1 hr 
at room temperature with 5% non-fat dry milk (Apex #20-241) in TBST (10 mM Tris,150 mM NaCl, 0.5% Tween 
20, pH 8.0), and incubated overnight at 4 °C with primary antibody. The next day, membranes were washed with 
TBST and incubated with appropriate secondary antibodies for 1 hour at room temperature. Membranes were 
washed with TBST and visualized using chemiluminescence SuperSignal West Dura Extended Substrate (Thermo 
#34075) and Bio-Rad Chemidoc system with Bio-Rad Image Lab software (version 4.0.1). Restore PLUS Stripping 
beffer (Thermo Fischer #46430) was used to strip blots of in between antibody sets, before probing with new 
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ones. The amount of proteins was quantified with densitometry analysis using Image J. Detailed information of 
antibodies used for Western Blot analysis are available in Supplementary Information.
Immunohistochemistry and quantification. Following transcardial perfusion with 4% paraform alde-
hyde, coronal brain sections (40 µm) of rats were cut with a sliding microtome (Microm HM400, Heidelberg). For 
mice brain sections (20 µm), brains were frozen and cut with CryoStar NX70 cryostat (ThermoFisher Scientific). 
Tissues were pretreated with 0.3% Triton-X in PBS for 30 min, followed by 1-hour incubation with normal don-
key serum, and then incubated overnight with primary antibodies at 4 °C, followed by a series of washing and the 
incubation with secondary antibodies at room temperature.
Chicken polyclonal anti-albumin (Abcam, AB106582; 1:300) and mouse monoclonal anti-parvalbumin 
(Sigma P3099, 1:1000) were used. Flourescein-labeled Wisteria Floribunda agglutinin (WFA, VectorLabs, 1:400) 
was used to detect perineuronal nets (PNNs). For secondary antibodies, we used cy3-anti-Chicken (Jackson 
ImmunoResearch Laboratories; 1:500) and Cy3-anti mouse (Jackon ImmunoResearch Laboratories; 1:500). 
Images were taken Zeiss 710 confocal microscope with 2 µm-optical slices. For quantification, three sections 
(200 µm apart) per animal were included for quantification. Region of interest (ROI) was traced at low magnifi-
cation using Stereoinvestigator (MBF Biosciences, Williston, VT). For rat brain sections, boundaries of partially 
isolated undercut cortices as well as contralateral homotopic somatosensory cortices were identified as ROI. For 
mice brain sections, cornu ammonis (CA) 1–3 areas were traced at low magnification since the icv albumin is 
infused into these areas of hippocampus as previously shown6. The percentage of PV(+)/WFA(+) cells among 
overall PV(+) cells was used as a measure of PNNs’ association with PV(+) cells. Experimenters were blinded to 
conditions throughout.
Human tissue. All participants gave informed and written consent and all procedures were conducted 
in accordance with the Declaration of Helsinki and approved by the local ethics committees of the individual 
institutions. For histopathological examination, resected hippocampi of patients and autopsy control tissue 
(Supplementary Table S2) were cut into 5 mm thick coronal slices along the anterior–posterior axis.
Tissue samples were fixed in 4% formalin and routinely processed into liquid paraffin. All specimens were cut 
at 4 µm with a microtome (Microm, Heidelberg, Germany), stretched in water at 40 °C and mounted on slides 
coated with silane (Langenbrinck). The slides were subsequently air-dried in an incubator at 37 °C overnight, dep-
araffined in descending alcohol concentration and stained with hematoxylin and eosin (HE) and HE-luxol-fast 
blue. Diagnostic procedures comprised various further routinely used immunohistochemical reactions including 
antibodies against glial fibrillary acidic protein (GFAP), synaptophysin, neurofilament protein (NFP) as described 
previously73, 74. After heat-induced antigen retrieval with sodium citrate buffer (pH 6.0), we used following anti-
bodies: mouse monoclonal anti-parvalbumin (Sigma, P3088; 1:200), chicken polyclonal anti-glial fibrillary 
acidic protein (Millipore, AB5541; 1:400), mouse monoclonal anti-GFAP (Cell Signaling, #3670; 1:50), rabbit 
polyclonal anti-pSmad2 (Millipore, AB3849; 1:2000), Cy3 anti-mouse IgG, Alexa647, anti-chicken IgG, Alexa488 
anti-mouse IgG, and Cy3 anti-rabbit IgG. All secondary antibodies were obtained from Jackson ImmunoResearch 
Labs and used at the dilution of 1:200. For quantification, images from 10 of randomly selected sampling areas 
per patient were collected using Zeiss Axio Observer Z1 epifluorescence microscopy equipped with Metamorph 
software for automatic cell scoring and image capturing. Experimenters were blinded to conditions throughout.
Statistical analysis. Prism6 (GraphPad) was used for statistical analysis. For mRNA data, one-way analy-
sis of variance (ANOVA) was used with Turkey’s post-hoc test. For immunohistochemistry, two-way ANOVA 
was used with Sidak’s post-hoc test if significant main (time or condition) or interaction effects were detected. 
Wilcoxon signed-rank test was used for the differential expression of eight ECM genes in matched-pair compar-
isons between array data sets. Mann-Whitney test was used to examine the effect of losartan in mice brains and 
used for human tissue analysis without assumption of normal distribution. Effects were considered significant at 
p < 0.05. Results are presented as the mean ± SE.
Additional detailed information on experimental procedures is available in Supplementary Information.
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